HEADER HYDROLASE 17-NOV-10 2XYD TITLE HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH TITLE 2 PHOSPHINIC TRIPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 30-639; COMPND 5 SYNONYM: ACE, DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II, CD143; COMPND 6 EC: 3.4.15.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: FINAL CONSTRUCT IS UNDERGLYCOSYALTED MUTANT AND COMPND 10 CONTAINS TWO MISMATCH MUTATIONS, P576L AND Q545R SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO K1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1 KEYWDS HYDROLASE, ZINC METALLOPEPTIDASE EXPDTA X-RAY DIFFRACTION AUTHOR M.AKIF,S.L.SCHWAGER,C.S.ANTHONY,B.CZARNY,F.BEAU,V.DIVE,E.D.STURROCK, AUTHOR 2 K.R.ACHARYA REVDAT 3 29-JUL-20 2XYD 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 11-APR-12 2XYD 1 REMARK VERSN REVDAT 1 11-MAY-11 2XYD 0 JRNL AUTH M.AKIF,S.L.SCHWAGER,C.S.ANTHONY,B.CZARNY,F.BEAU,V.DIVE, JRNL AUTH 2 E.D.STURROCK,K.R.ACHARYA JRNL TITL NOVEL MECHANISM OF INHIBITION OF HUMAN JRNL TITL 2 ANGIOTENSIN-I-CONVERTING ENZYME (ACE) BY A HIGHLY SPECIFIC JRNL TITL 3 PHOSPHINIC TRIPEPTIDE. JRNL REF BIOCHEM.J. V. 436 53 2011 JRNL REFN ISSN 0264-6021 JRNL PMID 21352096 JRNL DOI 10.1042/BJ20102123 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 78859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4154 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.20 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5642 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE SET COUNT : 314 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9856 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 368 REMARK 3 SOLVENT ATOMS : 241 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : 0.01000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.258 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.205 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.155 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.912 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 10585 ; 0.008 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 14426 ; 1.160 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1220 ; 5.302 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 526 ;35.523 ;23.745 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1584 ;14.970 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 65 ;16.084 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1510 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8247 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 6099 ; 0.497 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9807 ; 0.935 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4486 ; 1.285 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 4612 ; 2.156 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES A130-A132 ARE DISORDERED REMARK 4 REMARK 4 2XYD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046272. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 84896 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3NXQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.06 M DIVALENT CATIONS, 0.1 M REMARK 280 TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 38 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 54 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 111 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 146 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 318 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 574 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PRO 605 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 38 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 54 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 111 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 146 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 318 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 574 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PRO 605 TO LEU REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 130 REMARK 465 ASN A 131 REMARK 465 LYS A 132 REMARK 465 PRO B 130 REMARK 465 ASN B 131 REMARK 465 LYS B 132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 56 CD OE1 OE2 REMARK 470 GLN A 70 CD OE1 NE2 REMARK 470 LEU A 129 CG CD1 CD2 REMARK 470 THR A 133 OG1 CG2 REMARK 470 THR A 135 OG1 CG2 REMARK 470 LYS A 341 CD CE NZ REMARK 470 GLU A 403 CD OE1 OE2 REMARK 470 LYS A 517 CE NZ REMARK 470 LYS A 542 CE NZ REMARK 470 GLU B 56 CD OE1 OE2 REMARK 470 GLN B 70 CD OE1 NE2 REMARK 470 LYS B 341 CD CE NZ REMARK 470 GLU B 403 CD OE1 OE2 REMARK 470 ARG B 413 CG CD NE CZ NH1 NH2 REMARK 470 THR B 415 OG1 CG2 REMARK 470 LYS B 517 CE NZ REMARK 470 LYS B 542 CE NZ REMARK 470 TYR B 607 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 12 48.81 -91.98 REMARK 500 ASN A 45 78.03 -171.01 REMARK 500 ASN A 203 67.59 27.88 REMARK 500 ASN A 203 68.15 27.11 REMARK 500 ALA A 258 25.54 49.14 REMARK 500 ARG A 340 16.04 59.73 REMARK 500 ASP B 2 160.21 -49.45 REMARK 500 ASN B 203 45.46 36.60 REMARK 500 LYS B 341 -51.21 -129.97 REMARK 500 ASN B 416 88.77 -69.45 REMARK 500 ASP B 417 -97.42 -129.05 REMARK 500 THR B 418 -42.41 -151.10 REMARK 500 GLN B 575 -51.44 -23.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG4 A 1625 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1620 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 361 NE2 REMARK 620 2 HIS A 365 NE2 97.5 REMARK 620 3 GLU A 389 OE1 97.2 104.8 REMARK 620 4 3ES A1611 OAG 93.4 83.6 165.3 REMARK 620 5 3ES A1611 OAD 114.5 137.4 98.4 67.9 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1619 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 361 NE2 REMARK 620 2 HIS B 365 NE2 98.2 REMARK 620 3 GLU B 389 OE1 89.6 107.5 REMARK 620 4 3ES B1611 OAD 112.3 142.5 94.4 REMARK 620 5 3ES B1611 PBY 111.2 115.8 127.4 33.3 REMARK 620 6 3ES B1611 OAG 100.2 85.2 162.7 68.8 35.6 REMARK 620 N 1 2 3 4 5 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: [(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY) REMARK 630 [(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-CARBONYL]-AMINO}ETHYL) REMARK 630 PHOSPHINYL]-2-[(3-PHENYLISOXAZOL-5-YL)METHYL]-1-OXO-PROPYL}AMINO)- REMARK 630 3-(4-HYDROXY-PHENYL) REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 3ES A 1611 REMARK 630 3ES B 1611 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: PHQ PPH 1JQ TYR REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IUL RELATED DB: PDB REMARK 900 HUMAN TACE G13 MUTANT REMARK 900 RELATED ID: 2IUX RELATED DB: PDB REMARK 900 HUMAN TACE MUTANT G1234 REMARK 900 RELATED ID: 2C6N RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N REMARK 900 DOMAIN WITH LISINOPRIL REMARK 900 RELATED ID: 1UZE RELATED DB: PDB REMARK 900 COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRIL AN THE HUMAN REMARK 900 TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 1O86 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME IN COMPLEX REMARK 900 WITH LISINOPRIL. REMARK 900 RELATED ID: 1UZF RELATED DB: PDB REMARK 900 COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN REMARK 900 TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME REMARK 900 RELATED ID: 2C6F RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN REMARK 900 RELATED ID: 1O8A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME (NATIVE). REMARK 900 RELATED ID: 2XY9 RELATED DB: PDB REMARK 900 HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH PHOSPHINIC REMARK 900 TRIPEPTIDE DBREF 2XYD A 1 610 UNP P12821 ACE_HUMAN 30 639 DBREF 2XYD B 1 610 UNP P12821 ACE_HUMAN 30 639 SEQADV 2XYD GLN A 9 UNP P12821 ASN 38 ENGINEERED MUTATION SEQADV 2XYD GLN A 25 UNP P12821 ASN 54 ENGINEERED MUTATION SEQADV 2XYD GLN A 82 UNP P12821 ASN 111 ENGINEERED MUTATION SEQADV 2XYD GLN A 117 UNP P12821 ASN 146 ENGINEERED MUTATION SEQADV 2XYD GLN A 289 UNP P12821 ASN 318 ENGINEERED MUTATION SEQADV 2XYD ARG A 545 UNP P12821 GLN 574 ENGINEERED MUTATION SEQADV 2XYD LEU A 576 UNP P12821 PRO 605 ENGINEERED MUTATION SEQADV 2XYD GLN B 9 UNP P12821 ASN 38 ENGINEERED MUTATION SEQADV 2XYD GLN B 25 UNP P12821 ASN 54 ENGINEERED MUTATION SEQADV 2XYD GLN B 82 UNP P12821 ASN 111 ENGINEERED MUTATION SEQADV 2XYD GLN B 117 UNP P12821 ASN 146 ENGINEERED MUTATION SEQADV 2XYD GLN B 289 UNP P12821 ASN 318 ENGINEERED MUTATION SEQADV 2XYD ARG B 545 UNP P12821 GLN 574 ENGINEERED MUTATION SEQADV 2XYD LEU B 576 UNP P12821 PRO 605 ENGINEERED MUTATION SEQRES 1 A 610 LEU ASP PRO GLY LEU GLN PRO GLY GLN PHE SER ALA ASP SEQRES 2 A 610 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR GLN SER SEQRES 3 A 610 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 A 610 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 A 610 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 A 610 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 A 610 ILE TRP GLN GLN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 A 610 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 A 610 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER GLN SEQRES 10 A 610 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 A 610 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 A 610 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 A 610 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 A 610 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 A 610 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 A 610 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 A 610 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 A 610 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 A 610 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 A 610 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 A 610 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 A 610 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 A 610 GLY TRP GLN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 A 610 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 A 610 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 A 610 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 A 610 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 A 610 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 A 610 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 A 610 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 A 610 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 A 610 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 A 610 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 A 610 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 A 610 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 A 610 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 A 610 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 A 610 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 A 610 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 A 610 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 A 610 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 A 610 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU ARG ALA SEQRES 43 A 610 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 A 610 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 A 610 TYR PHE GLN LEU VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 A 610 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 A 610 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY SEQRES 1 B 610 LEU ASP PRO GLY LEU GLN PRO GLY GLN PHE SER ALA ASP SEQRES 2 B 610 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR GLN SER SEQRES 3 B 610 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 B 610 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 B 610 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 B 610 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 B 610 ILE TRP GLN GLN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 B 610 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 B 610 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER GLN SEQRES 10 B 610 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 B 610 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 B 610 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 B 610 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 B 610 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 B 610 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 B 610 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 B 610 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 B 610 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 B 610 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 B 610 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 B 610 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 B 610 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 B 610 GLY TRP GLN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 B 610 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 B 610 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 B 610 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 B 610 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 B 610 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 B 610 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 B 610 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 B 610 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 B 610 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 B 610 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 B 610 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 B 610 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 B 610 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 B 610 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 B 610 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 B 610 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 B 610 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 B 610 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 B 610 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU ARG ALA SEQRES 43 B 610 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 B 610 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 B 610 TYR PHE GLN LEU VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 B 610 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 B 610 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY MODRES 2XYD ASN A 45 ASN GLYCOSYLATION SITE MODRES 2XYD ASN A 416 ASN GLYCOSYLATION SITE MODRES 2XYD ASN A 480 ASN GLYCOSYLATION SITE MODRES 2XYD ASN B 45 ASN GLYCOSYLATION SITE MODRES 2XYD ASN B 416 ASN GLYCOSYLATION SITE MODRES 2XYD ASN B 480 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET FUC C 2 10 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET FUC E 4 10 HET NAG F 1 14 HET FUC F 2 10 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 14 HET NAG H 2 14 HET BMA H 3 11 HET 3ES A1611 51 HET ZN A1620 1 HET CL A1621 1 HET PEG A1622 7 HET PEG A1623 7 HET PEG A1624 7 HET PG4 A1625 10 HET 3ES B1611 51 HET ZN B1619 1 HET CL B1620 1 HET PG4 B1621 13 HET P6G B1622 19 HET PEG B1623 7 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM 3ES [(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY) HETNAM 2 3ES [(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-CARBONYL]- HETNAM 3 3ES AMINO}ETHYL)PHOSPHINYL]-2-[(3-PHENYLISOXAZOL-5-YL) HETNAM 4 3ES METHYL]-1-OXO-PROPYL}AMINO)-3-(4-HYDROXY-PHENYL) HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM P6G HEXAETHYLENE GLYCOL HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 3 NAG 10(C8 H15 N O6) FORMUL 3 FUC 3(C6 H12 O5) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 9 3ES 2(C38 H38 N3 O9 P) FORMUL 10 ZN 2(ZN 2+) FORMUL 11 CL 2(CL 1-) FORMUL 12 PEG 4(C4 H10 O3) FORMUL 15 PG4 2(C8 H18 O5) FORMUL 20 P6G C12 H26 O7 FORMUL 22 HOH *241(H2 O) HELIX 1 1 ASP A 2 GLN A 6 5 5 HELIX 2 2 ASP A 13 THR A 44 1 32 HELIX 3 3 THR A 47 GLU A 77 1 31 HELIX 4 4 ILE A 79 PHE A 83 5 5 HELIX 5 5 ASP A 85 ARG A 96 1 12 HELIX 6 6 LEU A 98 LEU A 103 5 6 HELIX 7 7 PRO A 104 ALA A 125 1 22 HELIX 8 8 PRO A 141 SER A 150 1 10 HELIX 9 9 SER A 152 GLN A 188 1 37 HELIX 10 10 ASP A 193 TRP A 201 1 9 HELIX 11 11 THR A 206 ILE A 242 1 37 HELIX 12 12 TRP A 261 ASN A 263 5 3 HELIX 13 13 ILE A 264 VAL A 269 1 6 HELIX 14 14 VAL A 279 GLY A 287 1 9 HELIX 15 15 GLN A 289 LEU A 304 1 16 HELIX 16 16 PRO A 310 SER A 317 1 8 HELIX 17 17 THR A 352 LYS A 373 1 22 HELIX 18 18 PRO A 376 ARG A 380 5 5 HELIX 19 19 ASN A 384 SER A 400 1 17 HELIX 20 20 THR A 401 ILE A 408 1 8 HELIX 21 21 ASP A 417 ILE A 433 1 17 HELIX 22 22 PHE A 435 SER A 451 1 17 HELIX 23 23 PRO A 455 SER A 457 5 3 HELIX 24 24 ARG A 458 GLY A 472 1 15 HELIX 25 25 PHE A 484 LYS A 489 5 6 HELIX 26 26 TYR A 498 ALA A 519 1 22 HELIX 27 27 PRO A 524 CYS A 528 5 5 HELIX 28 28 SER A 533 GLY A 547 1 15 HELIX 29 29 PRO A 551 GLY A 561 1 11 HELIX 30 30 ALA A 567 ASN A 588 1 22 HELIX 31 31 ASP B 13 ASN B 45 1 33 HELIX 32 32 THR B 47 GLU B 77 1 31 HELIX 33 33 PRO B 78 PHE B 83 5 6 HELIX 34 34 ASP B 85 ARG B 96 1 12 HELIX 35 35 LEU B 98 LEU B 103 5 6 HELIX 36 36 PRO B 104 ALA B 125 1 22 HELIX 37 37 PRO B 141 SER B 150 1 10 HELIX 38 38 SER B 152 GLN B 188 1 37 HELIX 39 39 ASP B 193 TRP B 201 1 9 HELIX 40 40 THR B 206 GLY B 238 1 33 HELIX 41 41 TRP B 261 ASN B 263 5 3 HELIX 42 42 ILE B 264 VAL B 269 1 6 HELIX 43 43 VAL B 279 GLY B 287 1 9 HELIX 44 44 GLN B 289 LEU B 304 1 16 HELIX 45 45 PRO B 310 SER B 317 1 8 HELIX 46 46 THR B 352 TYR B 372 1 21 HELIX 47 47 PRO B 376 ARG B 380 5 5 HELIX 48 48 ASN B 384 ILE B 408 1 25 HELIX 49 49 THR B 418 ILE B 433 1 16 HELIX 50 50 PHE B 435 GLY B 452 1 18 HELIX 51 51 PRO B 455 SER B 457 5 3 HELIX 52 52 ARG B 458 GLY B 472 1 15 HELIX 53 53 PHE B 484 LYS B 489 5 6 HELIX 54 54 TYR B 498 ALA B 519 1 22 HELIX 55 55 PRO B 524 CYS B 528 5 5 HELIX 56 56 SER B 533 GLY B 547 1 15 HELIX 57 57 PRO B 551 GLY B 561 1 11 HELIX 58 58 ALA B 567 ASN B 588 1 22 SHEET 1 AA 2 LYS A 126 CYS A 128 0 SHEET 2 AA 2 CYS A 136 SER A 138 -1 O TRP A 137 N VAL A 127 SHEET 1 AB 2 ILE A 248 PRO A 249 0 SHEET 2 AB 2 ILE A 473 CYS A 474 1 N CYS A 474 O ILE A 248 SHEET 1 AC 2 SER A 333 ASP A 336 0 SHEET 2 AC 2 PHE A 343 LYS A 346 -1 O ARG A 344 N TRP A 335 SHEET 1 BA 2 VAL B 127 CYS B 128 0 SHEET 2 BA 2 CYS B 136 TRP B 137 -1 O TRP B 137 N VAL B 127 SHEET 1 BB 2 ILE B 248 PRO B 249 0 SHEET 2 BB 2 ILE B 473 CYS B 474 1 N CYS B 474 O ILE B 248 SHEET 1 BC 2 SER B 333 ASP B 336 0 SHEET 2 BC 2 PHE B 343 LYS B 346 -1 O ARG B 344 N TRP B 335 SSBOND 1 CYS A 128 CYS A 136 1555 1555 2.04 SSBOND 2 CYS A 330 CYS A 348 1555 1555 2.06 SSBOND 3 CYS A 516 CYS A 528 1555 1555 2.02 SSBOND 4 CYS B 128 CYS B 136 1555 1555 2.05 SSBOND 5 CYS B 330 CYS B 348 1555 1555 2.05 SSBOND 6 CYS B 516 CYS B 528 1555 1555 2.02 LINK ND2 ASN A 45 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN A 416 C1 NAG E 1 1555 1555 1.44 LINK ND2 ASN A 480 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 45 C1 NAG G 1 1555 1555 1.43 LINK ND2 ASN B 416 C1 NAG H 1 1555 1555 1.45 LINK ND2 ASN B 480 C1 NAG F 1 1555 1555 1.45 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O6 NAG E 1 C1 FUC E 4 1555 1555 1.44 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.44 LINK O6 NAG F 1 C1 FUC F 2 1555 1555 1.44 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.45 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.45 LINK O4 NAG H 2 C1 BMA H 3 1555 1555 1.45 LINK NE2 HIS A 361 ZN ZN A1620 1555 1555 2.04 LINK NE2 HIS A 365 ZN ZN A1620 1555 1555 1.99 LINK OE1 GLU A 389 ZN ZN A1620 1555 1555 1.92 LINK OAG 3ES A1611 ZN ZN A1620 1555 1555 2.34 LINK OAD 3ES A1611 ZN ZN A1620 1555 1555 2.23 LINK NE2 HIS B 361 ZN ZN B1619 1555 1555 1.95 LINK NE2 HIS B 365 ZN ZN B1619 1555 1555 2.01 LINK OE1 GLU B 389 ZN ZN B1619 1555 1555 2.08 LINK OAD 3ES B1611 ZN ZN B1619 1555 1555 2.05 LINK PBY 3ES B1611 ZN ZN B1619 1555 1555 2.70 LINK OAG 3ES B1611 ZN ZN B1619 1555 1555 2.39 CISPEP 1 ASP A 140 PRO A 141 0 8.83 CISPEP 2 TYR A 607 PRO A 608 0 -0.93 CISPEP 3 ASP B 140 PRO B 141 0 6.25 CISPEP 4 TYR B 607 PRO B 608 0 3.46 CRYST1 72.837 76.437 82.954 89.11 64.43 75.87 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013729 -0.003456 -0.006961 0.00000 SCALE2 0.000000 0.013491 0.001393 0.00000 SCALE3 0.000000 0.000000 0.013435 0.00000